BRMEC6 Colloquium 2016

The sixth Invest in ME Research Biomedical Research into ME Colloquium (BRMEC6)—CPD accredited—took place in London over two days: 1st–2nd June 2016.

Aimed at boosting international collaboration in ME research, it was opened by Dr Vicky Whittemore of the USA's National Institutes of Health (NIH).

With full CPD accreditation the Colloquium involved the most experienced researchers in areas such as immunology, virology, neurology and bioinformatics.

Chairing and participating in the meeting were members of the Invest in ME Research Advisory Board and the newly formed European ME Research Group (EMERG).

We again had most of the main biomedical research initiatives now occurring throughout the world represented at the meeting.

The research Colloquium was in London and preceded the IIMEC11 annual international biomedical research conference on 1st June 2016.


BRMEC6 - Day 1
Welcome to the 6th Invest in ME International Biomedical Research into ME Colloquium Dr Ian Gibson, UEA, UK Professor Jonathan Edwards, UCL, UK
NIH Research into ME Dr Vicky Whittemore, NIH, USA
Diagnosis (clinical) – Patient Stratification (including the following)
Clinical signs/symptoms of ME Professor Olli Polo, Tampere University, Finland
Diagnostics and Patient Stratification for Research Dr Amolak Bansal, Epsom & St Helier NHS Trust, UK
Protocols and Patient Databases for ME Dr Luis Nacul, LSHTM, UK
Big Data Approach: Severely Ill ME Cohort Professor Ron Davis, Stanford, USA
Chaired Discussion - Criteria to Use for ME/CFS Diagnosis Professor Angela Vincent, Oxford University, UK
Sample Standardisation SOPs for Research (including the following)
Biobank Samples and Protocols for UK/Europe Dr Eliana Lacerda, LSHTM, UK
Analysis Protocols for ME Professor Jonas Bergquist, Uppsala University, Sweden
Chaired discussion Sample Standardisation SOPs for Research Dr Jo Cambridge, UCL, UK
Biomarkers: 1 Data
Keynote Speech: Longitudinal Immunological & Virological Study for ME/CFS Biomarker Discovery Professor Eleanor Riley, LSHTM, UK
Biomarkers: 2 Imaging
Immune-Brain Communication and Relationship to Inflammation and Cohort Selection Challenges Dr Neil Harrison, Sussex University, UK
Neuroimaging in Clinical Practice in ME tbc
Chaired Discussion Neuroimaging in ME Research Professor Jonathan Edwards, UCL, UK
Biomarkers: 3 Mitochondria
Keynote Speech: Understanding and Preventing Mitochondrial Oxidative Damage Dr Mike Murphy, MRC and Cambridge University, UK
Mitochondria in ME/CFS Professor Maureen Hanson, Cornell University, USA
Chaired discussion/workshop with participants Professor Jonas Blomberg, Uppsala University, Sweden
Adjourn

BRMEC6 - Day 2
Summary Day 1 - Objectives of DAY 2 Dr Ian Gibson, UEA, UK Professor Jonathan Edwards, UCL, UK
Biomarkers: 4 Antibodies (including the following)
Autoantibodies in ME/CFS Professor Carmen Scheibenbogen, Charite, Berlin, Germany
Antibodies to small DNA viruses Professor Jonas Blomberg, Uppala Uuniversity, Sweden
Novel form of RNaseL Professor Elisa Oltra, Cell and Molecular Biology at the Universidad Católica de Valencia “San Vicente Mártir”,  Spain
B cell biology and ME Dr Jo Cambridge, UCL, UK Fane Mensah, UCL, UK
Chaired discussion Antibodies in ME/CFS Dr Juliá Blanco, IrsiCaixa, Institute for AIDS Research, Spai
Biomarkers: 5 Big Data Updates
Big Data Approach for ME/CFS at Columbia University Professor Mady Hornig, Columbia University, USA
Big Data Update from Stanford Professor Ron Davis, Standord Genome, USA
Recent discoveries from NCNED data set: Gene expression & Receptor id Dr Don Staines, NCNED, Australia
Chaired discussion - Challenges of Big Data Strategies Professor Jonas Bergquist, Uppsala University, Sweden
Biomarkers: 6 Phenotypes (including the following)
Glucocorticoid Resistance in ME Dr Amolak Bansal, Epsom & St. Helier NHS, UK
Exercise Data, Orthostatic Tachycardia and Proteomics in ME Professor James Baraniuk, Georgetown University, USA
Virome and Gut Microbiota in ME Professor Tom Wileman, UEA, UK
Gut Microbe and Metabolomic Study of ME/CFS Patients Dr Christopher Armstrong, Dept Biochemistry and Molecular Biology, University of Melbourne, Australia
Discussion: Phenotypes in ME/CFS Professor Simon Carding, UEA/IFR, UK
Systems Biology (including the following)
A Systems Biology approach Dr Travis Craddock, Nova Southeastern University, Miami, USA
Novel Treatments (including the following)
Novel Treatments - Immunoadsorption Professor Carmen Scheibenbogen, Charite Berlin, Germany
Medical Education - BMJ Update Professor James Baraniuk, Georgetown University, USA
SUMMARY of BRMEC6 - Objectives Status Dr Ian Gibson Professor Jonathan Edwards
Adjourn


Share this page:

Last updated: December 2025